Literature DB >> 26124189

MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.

Zhongliang Ma1, Xiang Qiu1, Detao Wang1, Yanli Li1, Bingjie Zhang1, Tianwei Yuan1, Jiali Wei1, Botao Zhao1, Xintai Zhao2, Jiatao Lou3, Yan Jin4, Youxin Jin5.   

Abstract

MicroRNAs play important roles in carcinogenesis and tumor progress. Lung cancer is the leading cause of cancer mortality worldwide. In this study, the function of miR-181a-5p was investigated in non-small-cell lung cancer (NSCLC). Results showed that miR-181a-5p was significantly decreased in NSCLC tissues and cell lines. The proliferation and migration of A549 cells transfected with miR-181a-5p mimic was significantly inhibited. Luciferase activity assay results demonstrated that two binding sites of Kras could be directly targeted by miR-181a-5p. Furthermore, Kras was down-regulated by miR-181a-5p at both transcriptional and translational levels. SiRNA-mediated Kras down-regulation could mimic the effects of miR-181a-5p mimic in A549 cells. Our findings suggest that miR-181a-5p plays a potential role in tumor suppression by partially targeting Kras and has the potential therapeutic application in NSCLC patients.
© The Author 2015. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.

Entities:  

Keywords:  miR-181a-5p; migration; non-small cell lung cancer; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26124189     DOI: 10.1093/abbs/gmv054

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  31 in total

1.  miR-181a-2 downregulates the E3 ubiquitin ligase CUL4A transcript and promotes cell proliferation.

Authors:  Venkateshwarlu Bandi; Sudhakar Baluchamy
Journal:  Med Oncol       Date:  2017-07-20       Impact factor: 3.064

2.  Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.

Authors:  Li Chen; Ning Hu; Chao Wang; Hongmian Zhao; Yueli Gu
Journal:  Cell Cycle       Date:  2018-01-29       Impact factor: 4.534

3.  MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.

Authors:  Onder Ozcan; Murat Kara; Onder Yumrutas; Esra Bozgeyik; Ibrahim Bozgeyik; Ozgur Ilhan Celik
Journal:  Tumour Biol       Date:  2015-12-07

4.  Association of miRNA 30c, miRNA 181a and miRNA 570 SNPs with Bladder Cancer Risk in North Indian Population: A Pilot Study.

Authors:  Archana Verma; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2020-04-04

5.  miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.

Authors:  Johannes Neu; Piotr Jan Dziunycz; Andreas Dzung; Karine Lefort; Martin Falke; Rémy Denzler; Sandra Nicole Freiberger; Guergana Iotzova-Weiss; Aleksandar Kuzmanov; Mitchell Paul Levesque; Gian-Paolo Dotto; Günther Franz L Hofbauer
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

6.  tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer.

Authors:  Yang Shao; Qiangling Sun; Xiaomin Liu; Ping Wang; Renqi Wu; Zhongliang Ma
Journal:  Chem Biol Drug Des       Date:  2017-05-22       Impact factor: 2.817

7.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

8.  Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.

Authors:  Yang Shao; Yu-Qing Shen; Yan-Li Li; Chen Liang; Bing-Jie Zhang; Sheng-Di Lu; Yan-Yun He; Ping Wang; Qiang-Ling Sun; You-Xin Jin; Zhong-Liang Ma
Journal:  Oncotarget       Date:  2016-06-07

Review 9.  Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.

Authors:  Xiaomin Liu; Ping Wang; Caiyan Zhang; Zhongliang Ma
Journal:  Oncotarget       Date:  2017-07-25

Review 10.  mTOR signaling-related MicroRNAs and Cancer involvement.

Authors:  Ping Wang; Xiao-Min Liu; Lei Ding; Xin-Ju Zhang; Zhong-Liang Ma
Journal:  J Cancer       Date:  2018-01-08       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.